Celsius Holdings (CELH) versus Its Rivals Head-To-Head Contrast
Celsius Holdings (NASDAQ: CELH) is one of 104 publicly-traded companies in the “Pharmaceuticals” industry, but how does it compare to its peers? We will compare Celsius Holdings to similar businesses based on the strength of its valuation, analyst recommendations, risk, dividends, earnings, profitability and institutional ownership.
This table compares Celsius Holdings and its peers’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Celsius Holdings Competitors||-2,399.97%||-68.06%||-7.34%|
This is a breakdown of current ratings for Celsius Holdings and its peers, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Celsius Holdings Competitors||863||3776||6743||178||2.54|
Celsius Holdings currently has a consensus target price of $7.00, suggesting a potential upside of 32.83%. As a group, “Pharmaceuticals” companies have a potential upside of 22.20%. Given Celsius Holdings’ stronger consensus rating and higher possible upside, equities research analysts plainly believe Celsius Holdings is more favorable than its peers.
Volatility & Risk
Celsius Holdings has a beta of -0.7, meaning that its stock price is 170% less volatile than the S&P 500. Comparatively, Celsius Holdings’ peers have a beta of 37.04, meaning that their average stock price is 3,604% more volatile than the S&P 500.
Insider and Institutional Ownership
2.5% of Celsius Holdings shares are held by institutional investors. Comparatively, 44.2% of shares of all “Pharmaceuticals” companies are held by institutional investors. 49.0% of Celsius Holdings shares are held by company insiders. Comparatively, 11.3% of shares of all “Pharmaceuticals” companies are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Earnings & Valuation
This table compares Celsius Holdings and its peers top-line revenue, earnings per share and valuation.
|Gross Revenue||NetIncome||Price/Earnings Ratio|
|Celsius Holdings||$22.76 million||-$3.06 million||-58.56|
|Celsius Holdings Competitors||$8.17 billion||$1.09 billion||121.43|
Celsius Holdings’ peers have higher revenue and earnings than Celsius Holdings. Celsius Holdings is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.
About Celsius Holdings
Celsius Holdings, Inc. is engaged in the development, marketing, sale and distribution of functional calorie-burning fitness beverages under the Celsius brand name. The Company’s product range includes Sparkling Grape Rush, Sparkling Watermelon, Sparkling Orange, Sparkling Wild Berry, Sparkling Cola, Raspberry Acai Green Tea, Peach Mango Green Tea, Flo Fusion Orange and Flo Fusion Berry. The Company’s products are sweetened with sucralose, which is suitable for consumers whose sugar intake is restricted. The Company’s Celsius brand uses ingredients and supplements, such as green tea (EGCG), ginger, calcium, chromium, B vitamins and vitamin C. The Company outsources the manufacturing process to third-party co-packers. It provides co-packers with flavors, ingredient blends, cans and other raw materials for its beverages purchased by it from various suppliers. It sells Celsius brand across retail segments, which include supermarkets and convenience stores.
Receive News & Ratings for Celsius Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celsius Holdings Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.